The co-founder of Valkyrie Investments and its current CIO, Steven McClurg, indicated to industry portal The Block that he expects approvals for spot Bitcoin ETFs to be approved tomorrow evening, with trading starting as early as Thursday. Just before the news, there was a strong downward move on Bitcoin, which was quickly erased. It's still likely that U.S. regulators will hold off on a final decision on spot ETFs until tomorrow.
- Most of the smaller projects are seeing declines today. Filecoin and Apecoin are losing around 6%, and STEPN's discount is approaching the 10% area. Ethereum loses 2.6% and is trading near $2,200. Bitcoin encountered strong resistance above $47,000 but reaction after Valkyrie communicate suggest that bulls are still active. The dollar index is gaining 0.14%, putting pressure on risky assets, and declines are also seen on European and US stock exchanges.
Bitcoin chart (M30)
The largest of the cryptocurrencies halted declines after a dynamic correction that reached $45.500. Currently, the bulls are back above $46,500, but it seems that ahead of the SEC decision, BTC may struggle to climb to new highs this year. Looking at the range of the previous three major price moves, in the event of a further correction, Bitcoin's price could test the area between $42,000 and $43,000, where we see previous price reactions and the 23.6 Fibonacci retracement of the October 2023 upward wave. Still, the upward move cannot be excluded and the key may be $50,000 psychological support level.

Source: xStation5
Daily Summary: Technology Drives Wall Street to Record Highs Despite Tensions in the Persian Gulf
Morning Wrap: USโIran Peace Talks in the Shadow of Trumpโs Ultimatum
Technical analysis: Bitcoin gains and approaches important resistance zone
Crypto news ๐ Bitcoin rebounds approaching $80k level
The material on this page does not constitute as financial advice and does not take into account your level of understanding, investment objectives, financial situation or any other particular needs.
All the information provided, including opinions, market research, mathematical results and technical analyses published on the website or transmitted to you by other means is provided for information purposes only and should in no event be interpreted as an offer of, or solicitation for, a transaction in any financial instrument, nor should the information provided be construed as advice of legal or fiscal nature.
Any investment decisions you make shall be based exclusively on your level of understanding, investment objectives, financial situation or any other particular needs. Any decision to act on information published on the website or transmitted to you by other means is entirely at your own risk. You are solely responsible for such decisions.
If you are in doubt or are not sure that you understand a particular product, instrument, service, or transaction, you should seek professional or legal advice before trading.
Investing in OTC Derivatives carries a high degree of risk, as they are leveraged based products and often small movements in the market could lead to much larger movements in the value of your investment and this could work against you or for you. Please ensure that you fully understand the risks involved, taking into account your investments objectives and level of experience, before trading, and if necessary, seek independent advice.